These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
145 related articles for article (PubMed ID: 38771048)
41. Role of the airway epithelium in defense against inhaled invaders. Jay AN COPD; 2005 Sep; 2(3):285-7. PubMed ID: 17146993 [No Abstract] [Full Text] [Related]
42. Of Mucus and Microbes: The Sticky Issue of Mucin-Microbiome Interactions in Chronic Obstructive Pulmonary Disease. Huang YJ Am J Respir Crit Care Med; 2024 Aug; 210(3):252-253. PubMed ID: 38530107 [No Abstract] [Full Text] [Related]
43. Mucins, mucus, and sputum. Voynow JA; Rubin BK Chest; 2009 Feb; 135(2):505-512. PubMed ID: 19201713 [TBL] [Abstract][Full Text] [Related]
44. Impact of Smoking and Chronic Obstructive Pulmonary Disease on All-Cause, Respiratory, and Cardio-Cerebrovascular Mortality. Kang HR; Kim SJ; Nam JG; Park YS; Lee CH Int J Chron Obstruct Pulmon Dis; 2024; 19():1261-1272. PubMed ID: 38863653 [TBL] [Abstract][Full Text] [Related]
45. Mucus plugging on computed tomography and the sputum microbiome in patients with asthma, chronic obstructive pulmonary disease, and asthma-COPD overlap. Tanabe N; Matsumoto H; Morimoto C; Hayashi Y; Sakamoto R; Oguma T; Nagasaki T; Sunadome H; Sato A; Sato S; Ohashi K; Tsukahara T; Hirai T Allergol Int; 2024 Oct; 73(4):515-523. PubMed ID: 39013753 [TBL] [Abstract][Full Text] [Related]
47. Mucoactive and antioxidant medicines for COPD: consensus of a group of Chinese pulmonary physicians. Yan X; Song Y; Shen C; Xu W; Chen L; Zhang J; Liu H; Huang M; Lai G; Qian G; Wang J; Ye X; Zheng J; Bai C Int J Chron Obstruct Pulmon Dis; 2017; 12():803-812. PubMed ID: 28405161 [TBL] [Abstract][Full Text] [Related]
49. Increased expression of human calcium-activated chloride channel 1 is correlated with mucus overproduction in the airways of Chinese patients with chronic obstructive pulmonary disease. Wang K; Feng YL; Wen FQ; Chen XR; Ou XM; Xu D; Yang J; Deng ZP Chin Med J (Engl); 2007 Jun; 120(12):1051-7. PubMed ID: 17637221 [TBL] [Abstract][Full Text] [Related]
50. Neuropeptides in asthma, chronic obstructive pulmonary disease and cystic fibrosis. Atanasova KR; Reznikov LR Respir Res; 2018 Aug; 19(1):149. PubMed ID: 30081920 [TBL] [Abstract][Full Text] [Related]
51. New pharmacotherapy for airway mucus hypersecretion in asthma and COPD: targeting intracellular signaling pathways. Lai H; Rogers DF J Aerosol Med Pulm Drug Deliv; 2010 Aug; 23(4):219-31. PubMed ID: 20695774 [TBL] [Abstract][Full Text] [Related]
52. Prediction of mortality in patients with chronic obstructive pulmonary disease with the new Global Initiative for Chronic Obstructive Lung Disease 2017 classification: a cohort study. Gedebjerg A; Szépligeti SK; Wackerhausen LH; Horváth-Puhó E; Dahl R; Hansen JG; Sørensen HT; Nørgaard M; Lange P; Thomsen RW Lancet Respir Med; 2018 Mar; 6(3):204-212. PubMed ID: 29331311 [TBL] [Abstract][Full Text] [Related]
53. Oxygen With Cold Bubble Humidification Is No Better Than Dry Oxygen in Preventing Mucus Dehydration, Decreased Mucociliary Clearance, and Decline in Pulmonary Function. Franchini ML; Athanazio R; Amato-Lourenço LF; Carreirão-Neto W; Saldiva PH; Lorenzi-Filho G; Rubin BK; Nakagawa NK Chest; 2016 Aug; 150(2):407-14. PubMed ID: 27048871 [TBL] [Abstract][Full Text] [Related]
54. β2-Adrenoceptor involved in smoking-induced airway mucus hypersecretion through β-arrestin-dependent signaling. Zhou Y; Zhang Y; Guo Y; Zhang Y; Xu M; He B PLoS One; 2014; 9(6):e97788. PubMed ID: 24905583 [TBL] [Abstract][Full Text] [Related]
55. Airway mucus, inflammation and remodeling: emerging links in the pathogenesis of chronic lung diseases. Zhou-Suckow Z; Duerr J; Hagner M; Agrawal R; Mall MA Cell Tissue Res; 2017 Mar; 367(3):537-550. PubMed ID: 28108847 [TBL] [Abstract][Full Text] [Related]
56. Interleukin-6 neutralizing antibody attenuates the hypersecretion of airway mucus via inducing the nuclear translocation of Nrf2 in chronic obstructive pulmonary disease. Wei YY; Zhang DW; Ye JJ; Lan QX; Ji S; Sun L; Li F; Fei GH Biomed Pharmacother; 2022 Aug; 152():113244. PubMed ID: 35687911 [TBL] [Abstract][Full Text] [Related]
57. Identification of pendrin as a common mediator for mucus production in bronchial asthma and chronic obstructive pulmonary disease. Nakao I; Kanaji S; Ohta S; Matsushita H; Arima K; Yuyama N; Yamaya M; Nakayama K; Kubo H; Watanabe M; Sagara H; Sugiyama K; Tanaka H; Toda S; Hayashi H; Inoue H; Hoshino T; Shiraki A; Inoue M; Suzuki K; Aizawa H; Okinami S; Nagai H; Hasegawa M; Fukuda T; Green ED; Izuhara K J Immunol; 2008 May; 180(9):6262-9. PubMed ID: 18424749 [TBL] [Abstract][Full Text] [Related]
58. [Frailty is associated with increased mortality in chronic obstructive pulmonary disease]. Patino-Hernandez D; Borda MG; Cano-Gutiérrez CA; Celis-Preciado CA; Pérez-Zepeda MU Rev Esp Geriatr Gerontol; 2019; 54(4):237-238. PubMed ID: 30598302 [No Abstract] [Full Text] [Related]
59. The role of airway secretions in COPD: pathophysiology, epidemiology and pharmacotherapeutic options. Rogers DF COPD; 2005 Sep; 2(3):341-53. PubMed ID: 17146999 [TBL] [Abstract][Full Text] [Related]
60. Chronic Mucus Hypersecretion and the Natural History of Chronic Obstructive Pulmonary Disease. Lange P; Vestbo J Am J Respir Crit Care Med; 2016 Mar; 193(6):602-3. PubMed ID: 26977967 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]